TP53 Mutations Orchestrate an Immunosuppressive Malignant-Myeloid Niche to Dictate Therapeutic Vulnerability in PDAC
Abstract
Data about TP53 Mutations Orchestrate an Immunosuppressive Malignant-Myeloid Niche to Dictate Therapeutic Vulnerability in PDAC review
Fields of Study & Subjects
Pancreatic and Hepatic Oncology Research
Cancer Immunotherapy and Biomarkers
Immune cells in cancer
Publication details
- Journal / source
- Zenodo (CERN European Organization for Nuclear Research)
- Publication date
- 27 January 2026
- Language
- EN
- Document type
- Dataset